Success

Alert

Please select a Day.

Info

Dr Lal PathLabs Ltd.

Sector : Healthcare | Industry : Hospital & Healthcare Services

Follow Following

Score

78/100

3,153.70

-101.20 (-3.11%)

As on 04 Nov, 2025 | 03:59

Open Trading A/c

Dividend : Interim Dividend of Rs.7 on 07/11/2025.

Day Range

3130.10

3250.00

L H

52 Week Range

2293.55

3540.00

L H

Volume

144,892

* BSE Market Depth (04 Nov 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
1	3150.00	3160.00	8
8	3148.40	3163.00	100
8	3147.45	3168.00	10
57	3145.75	3171.35	63
5	3145.00	3171.55	63
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Advance Chart

Score

78/100

3,160.00

-91.65 (-2.82%)

As on 04 Nov, 2025 | 04:01

Open Trading A/c

Dividend : Interim Dividend of Rs.7 on 07/11/2025.

Day Range

3133.00

3253.05

L H

52 Week Range

2295.10

3542.60

L H

Volume

6,170

* BSE Market Depth (04 Nov 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
1	3150.00	3160.00	8
8	3148.40	3163.00	100
8	3147.45	3168.00	10
57	3145.75	3171.35	63
5	3145.00	3171.55	63
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Advance Chart

Dr Lal PathLab

3,153.70

-101.20(-3.11%)

NSE

#KnowBeforeYouInvest
Forecast

MC Essentials

88% Pass

MC Technicals

This represents current trend.Click here for disclaimer.

Trend

MC Insights

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials

Ownerships

Industry Comparison

Others

Overview
Chart
Forecast
MC Insights
MC Technicals
Scans
Price & Volume
Seasonality Analysis
News
Forum
Research
Deals
Corp Action
Financials
Shareholding
Financials Shareholding Peers About

Open	3,249.80
Previous Close	3,254.90
Volume	144,892.00
Value (Lacs)	4,569.46
VWAP	3,165.15
Beta	0.47 0.44
Mkt Cap (Rs. Cr.)	26,420

High	3,250.00
Low	3,130.10
UC Limit	3,905.80
LC Limit	2,604.00
52 Week High	3,540.00
52 Week Low	2,293.55
Face Value	10.00

All Time High	4,245.50
All Time Low	696.50
20D Avg Volume	150,165
20D Avg Delivery(%)	46.13
Book Value Per Share	238.95
Dividend Yield	0.76

TTM EPS See historical trend	63.80 (+32.88% YoY)
TTM PE See historical trend	49.43 (Low PE)
P/B See historical trend	13.20 (Average P/B)
Sector PE	49.66

Advanced Chart

Click here to expand

*Delayed by 20 seconds.

Forecast

Share Price Forecast

Earnings Forecast

Actuals Estimates

ANNUALLY

(Rs.)

EPS
Net Profit
Revenue

Valuations

Consensus Recommendations

Buy
Outperform
Hold
Underperform
Sell

Hits/Misses

QUARTERLY (Rs.)

EPS
Net Profit
Revenue

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

MC Insights

Stock Score

78/100

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Get detailed analysis with Moneycontrol Stock Insights.

Price

10.91% away from 52 week high

Financials

Piotroski Score

indicates

Industry Comparison

Market Cap - Above Median

Shareholding Pattern

Promoters decreased holding from 53.79% to 53.21% in Sep 2025 qtr.

MC Technicals

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages

Days
5	- -
10	- -
20	- -
50	- -
100	- -
200	- -

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Moving Averages

Days

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Moving Averages

Days

Price and Volume

Price Performance

1 Week		--%
1 Month		--%
3 Months		--%
YTD		--%
1 Year		--%
3 Years		--%

Volume Analysis

Volume
Delivery

SEASONALITY ANALYSIS

5 out of 10 years Dr Lal PathLabs has given positive returns in November.

Month	Max. Positive Change(%)	Avg. Positive Change(%)	Max. Negative Change(%)	Avg. Negative Change(%)	Average Change(%)
November	15.18% (2017)	7.45%	-4.58% (2022)	-2.49%	2.48%

Seasonality Analysis

News

Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y

Oct 31 2025 06:54 PM

Dr Lal PathLabs shares jump 3% as firm's board to consider bonus issue on October 31 Oct 27 2025 05:31 PM
Stocks to Watch Today: Coforge, NCC, Kotak Bank, GPT Infra, Vikran Engineering, Eclerx, Container Corporation, RailTel, Thyrocare, IOC in focus on 27 October Oct 27 2025 02:47 AM
Dr. Lal PathLabs to Hold Analyst/Institutional Investor Meetings in September 2025 Aug 26 2025 12:02 PM
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y Aug 01 2025 01:47 PM

Earning + See More

Forum

Community Sentiments

100% BUY
0% SELL
0% HOLD

100%

of moneycontrol users recommend buying Dr Lal PathLab

What's your call on Dr Lal PathLab today?

Read 0 investor views

BUY SELL HOLD

sidmahato123
Dr Lal PathLab
Follow

1 days ago

when the anytime Will come View more

Posted by : sidmahato123
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  when the anytime Will come
  
  Repost Cancel
You will now receive notification when someone reply to this message.
Tota7575
Dr Lal PathLab
Follow

2 days ago

Anytime big spike maybe happened. View more | 1

Posted by : Tota7575
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Anytime big spike maybe happened.
  
  Repost Cancel
You will now receive notification when someone reply to this message.
The Fixed Income
Bonds
Follow

2 days ago

Sponsored Post
Diversify Your Investment Portfolio with Government Security KARNATAKA SDL 2029 ✔️ Coupon: 8.30% ✔️ Tenor: 3y 3m (Maturity: 20/Feb/2029) G-Sec | Listed | Sovereign-Backed Enjoy the reliability of government-backed returns while earning a steady income from a trusted and secure investment avenue. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhdllnPT0=/830-karnataka-sdl-2029?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more

Posted by : The Fixed Income
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Diversify Your Investment Portfolio with Government Security KARNATAKA SDL 2029 ✔️ Coupon: 8.30% ✔️ Tenor: 3y 3m (Maturity: 20/Feb/2029) G-Sec | Listed | Sovereign-Backed Enjoy the reliability of government-backed returns while earning a steady income from a trusted and secure investment avenue. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJhdllnPT0=/830-karnataka-sdl-2029?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
  
  Repost Cancel
You will now receive notification when someone reply to this message.

+ See More

Broker Research

20 Jul, 2025

Emkay Global Financial Services

Reco Price 3000.75

Target Price 3100

26 Apr, 2025

ICICI Securities

Reco Price 2906.55

Target Price 2900

26 Apr, 2025

Emkay Global Financial Services

Reco Price 2906.55

Target Price 3100

30 Jan, 2025

Emkay Global Financial Services

Reco Price 2879.40

Target Price 3250

24 Oct, 2024

ICICI Securities

Reco Price 3053.50

Target Price 3100

08 Aug, 2024

ICICI Securities

Reco Price 3194.75

Target Price 3240

REFINITIV Report

20 Oct, 2025

Goldman Sachs Bank Europe Se - Odi

Qty 33414

Price 3160

% Traded 0.04

20 Oct, 2025

Goldman Sachs (singapore) Pte - Odi

Qty 33414

Price 3160

% Traded 0.04

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

06 Jan, 2025

Multi-manager Icvc

Qty 434943

Price 2997.11

% Traded 0.52

*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

Corporate Action

01 Nov, 2025 | 01:48PM

Announcement under Regulation 30 (LODR)-Newspaper Publication
Attached
01 Nov, 2025 | 09:19AM

Receipt Of An Assessment Order And Demand Notice Issued By Income Tax Department
Attached
31 Oct, 2025 | 06:56PM

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attached

+ See More

Date	Agenda

+ See More

Ex-Date	Type	Dividend (Rs)

+ See More

Announcement Date	Ex-Bonus	Ratio

+ See More

Ex-Split	Old FV	New FV

+ See More

Ex-Right	Ratio	Premium

+ See More

Date	Agenda

+ See More

Financials

Consolidated
Standalone

Quarterly Annually

(Rs. Cr)

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

(Rs. Cr)

Revenue

Net Profit

BVPS

Debt to Equity

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

Shareholding

Summary

See Top Holdings

Trend

PEERS

Company Name	Price	% Chg	MCap(Cr)	TTM PE	P/B	ROE(%)	1 Yr Perform(%)	Net Profit(Rs.)	Net Sales(Rs.)	Debt to Equity
Dr Lal PathLab	3,153.70	-3.11	26,420.28	49.43	13.20	22.42	2.64	492	2,461	0.00
Apollo Hospital	7,810.50	-0.18	112,303.01	71.37	14.97	17.60	12.25	1,472	21,794	0.64
Max Healthcare	1,138.40	-0.65	110,679.40	96.47	12.58	11.46	9.82	1,075	7,028	0.27
Fortis Health	1,019.10	-1.13	76,937.78	88.62	9.80	8.68	60.48	797	7,782	0.25
Narayana Hruda	1,830.30	2.54	37,404.16	47.63	11.67	21.80	51.11	789	5,482	0.61

+ See More

About the Company

Dr. Lal Pathlabs Private Limited is recognized as a centre of innovation and a premier clinical pathology laboratory. It is the largest and most respected diagnostic service provider in the country.

Registered Office
- Address
  Block E, ,Sector 18, ,Rohini,
- City
  New Delhi
- State
  Delhi
- Pin Code
  110085
- Tel. No.
  011-49885050
- Fax No.
  011-27882134
- Email
  cs@lalpathlabs.com
- Internet
  https://www.lalpathlabs.com
Registrars
- Address
  Noble Heights, Ist Floor, Plot NH 2, C-1 Block LS,
- City
  New Delhi 110058
- State
  Delhi
- Tel. No.
  011-49411000
- Fax No.
  011-41410591
- Email
  delhi@linkintime.co.in
- Internet
  http://www.linkintime.co.in
Management
- Arvind Lal
  Executive Chairman
- Vandana Lal
  Whole Time Director
- Archana Lal Erdmann
  Non Executive Director
- Rahul Sharma
  Non Executive Director
- Arun Duggal
  Independent Director
+ See More
Included In
- BSE 100
  No
- BSE 200
  No
- SENSEX
  No
- CNX MIDCAP 200
  No
- NIFTY 50
  No
- BSE 500
  Yes
- Nifty 200
  No
Details
- BSE:
  539524
- NSE:
  LALPATHLAB
- Series
  EQ
- ISIN
  INE600L01024